Up a level |
Miles, David and Cameron, David and Bondarenko, Igor and Manzyuk, Lyudmila and Alcedo, Juan Carlos and Lopez, Roberto Ivan and Im, Seock-Ah and Canon, Jean-Luc and Shparyk, Yaroslav and Yardley, Denise A and Masuda, Norikazu and Ro, Jungsil and Denduluri, Neelima and Hubeaux, Stanislas and Quah, Cheng and Bais, Carlos and O'Shaughnessy, Joyce (2017) Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation. European journal of cancer, 70. pp. 146-155. ISSN 1879-0852